Want to see AU:SHL full AI Analyst Report?
Earnings Data
Report Date
Aug 20, 2026TBA (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
0.67Last Year’s EPS
0.58Same Quarter Last Year
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a broadly positive operational and financial position — solid H1 results, maintained full-year EBITDA guidance, margin expansion (+30 bps), diversified organic growth across key markets (Germany, Australia, UK, Radiology) and progress on acquisitions, digital pathology and capital management initiatives (dividend increase, sale-and-leaseback program). Headwinds are meaningful but generally manageable: U.S. margin pressure and restructuring, slower revenue-collection benefits pushed into FY2027, working-capital distortion from a Change Healthcare cyber incident, higher net debt from acquisitions/property spending, FX uncertainty and pending Australian wage decisions. Management emphasizes operating leverage, synergy capture and disciplined capital allocation to address these challenges.Company Guidance
Strong H1 Financial Results
Revenue of $5.445 billion, EBITDA of $907 million and net profit of $262 million for H1 FY2026; EPS AUD 0.531. Management maintained full-year adjusted EBITDA guidance of $1.87bn–$1.95bn (constant currency).
Organic Revenue Growth
Group organic growth of 5% in H1 FY2026, with particularly strong contributions from Australian Pathology (organic +5%) and other divisions.
Regional Outperformance and High-Growth Markets
Germany delivered 40% revenue growth on a constant currency basis (organic +5%); United Kingdom organic growth +24% driven by Hertfordshire & West Essex contract; Radiology organic revenue growth +7%; Sonic Clinical Services revenue +5% with EBITDA growth +20% (from a low base).
Margin Expansion and Operating Leverage
Adjusted EBITDA margins increased by ~30 basis points year-on-year (H1 2025 → H1 2026) and management highlights operating leverage and synergy realization across most businesses.
Acquisitions and Integration Progress
LADR (Germany) settled 1 July 2025 and integration across 16 workstreams is progressing to plan; Cairo Diagnostics and ThyroSeq included in an expanded Advanced Diagnostics division; >60% of dermatopathology volume now on proprietary PathologyWatch digital platform.
Capital Management and Balance Sheet Flexibility
Interim dividend increased by 2.3% to AUD 0.45 (60% franked); target medium-term payout ratio 70–80%. Debt cover ratio at 2.5x and available headroom ~US$1 billion before interim dividend. Sale-and-leaseback program initiated to unlock capital and fund potential on-market buybacks.
Reduced Depreciation Guidance and More Transparency Below EBITDA
Depreciation forecast lowered to $770m–$780m (constant currency). Management provided tighter below-EBITDA guidance (depreciation, interest and tax rate guidance at 27%).
Operational Wins and Productivity Initiatives
Major lab platform procurement completed delivering substantial savings; new hub labs (e.g., Watford, Melbourne Docklands) and automation investments underway; partnership with National Lung Cancer Screening Program boosting CT volumes.
AU:SHL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AU:SHL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 18, 2026 | AU$20.84 | AU$22.89 | +9.89% |
Aug 20, 2025 | AU$27.45 | AU$23.92 | -12.84% |
Feb 19, 2025 | AU$27.10 | AU$26.36 | -2.74% |
Aug 21, 2024 | AU$25.46 | AU$25.67 | +0.79% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sonic Healthcare Limited (AU:SHL) report earnings?
Sonic Healthcare Limited (AU:SHL) is schdueled to report earning on Aug 20, 2026, TBA (Confirmed).
What is Sonic Healthcare Limited (AU:SHL) earnings time?
Sonic Healthcare Limited (AU:SHL) earnings time is at Aug 20, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Sonic Healthcare Limited stock?
The P/E ratio of Sonic Healthcare Limited is N/A.
What is AU:SHL EPS forecast?
AU:SHL EPS forecast for the fiscal quarter 2026 (Q4) is 0.67.